Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $44.45 and last traded at $44.45, with a volume of 0 shares traded. The stock had previously closed at $44.45.
Basilea Pharmaceutica Price Performance
The stock’s 50 day moving average is $42.16 and its 200-day moving average is $41.15.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
See Also
- Five stocks we like better than Basilea Pharmaceutica
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Invest in Biotech Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- What is a SEC Filing?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
